Document:

EX-10.39

 Exhibit 10.39 

Execution Version 

CONSULTING AGREEMENT 

This Consulting Agreement is entered into as of March 21, 2015 (this “Agreement”) by and between Actavis plc (the
“Company”), and David Buchen (the “Consultant” and, together with the Company, the “Parties”). 

RECITALS 
 WHEREAS,
the Company, Avocado Acquisition Inc., an indirect wholly owned subsidiary of the Company, and Allergan Inc. (“Allergan”) have entered into that certain Agreement and Plan of Merger, dated as of November 16, 2014 (the
“Merger Agreement”), pursuant to which Allergan will become a wholly-owned subsidiary of the Company upon consummation of the Merger (as defined in the Merger Agreement); 

WHEREAS, the Consultant has served the Company and its affiliates, including as the Company’s Chief Legal Officer and Executive Vice
President Commercial, North American Generics and International, and has considerable knowledge and experience with respect to the Company’s operations; 

WHEREAS, the Consultant and the Company have agreed that the Consultant’s employment with the Company and its affiliates will terminate
on May 1, 2015 (the “Employment Cessation Date”); 
 WHEREAS, the Company has determined that it is in its best
interests for the Consultant to make available his continued services and expertise to the Company following the Employment Cessation Date, for the consideration and on the terms and conditions set forth below; and 

NOW, THEREFORE, in consideration of the mutual promises, covenants, representations and warranties made herein and intending to be legally
bound, the Parties hereto agree as follows: 
 Section 1 Engagement 

1.1 Services. Upon the terms and subject to the conditions of this Agreement, the Company hereby engages the Consultant, and the
Consultant hereby accepts such engagement, as an independent contractor to provide the services set forth in Annex A and any other such consulting services as may be requested from time to time by the Executive Vice President Chief Operating
Officer (collectively, the “Services”). Notwithstanding any provision of this Agreement to the contrary, the Company and the Consultant currently intend and anticipate that (i) as of the Employment Cessation Date, the
Consultant shall have a “separation from service” (within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”)) from the Company and (ii) the amount of time the Consultant
shall provide the Services during the Term shall be less than twenty percent (20%) of the average level of bona fide services performed by the Consultant during the thirty-six (36) month period preceding the Employment Cessation Date. 

 1.2 Location. During the Term, the Consultant shall be available to provide the Services
remotely (via phone, e-mail or fax), provided, however that at the option of the Company, Consultant shall be required to attend meetings with the Company’s management from time to time as reasonably requested by the Company. 

1.3 Term of Agreement. This term of this Agreement shall commence upon the Employment Cessation Date and shall continue until
May 1, 2016 (the “Termination Date”), unless earlier terminated in accordance with Section 1.4 (the “Term”). 

1.4 Termination. The Company may terminate this Agreement and the Term at any time for Cause (as defined below) and either Party may
terminate this Agreement without Cause, pursuant to a Notice of Termination (as defined below), which, in the case of a termination without Cause shall be delivered at least ten (10) days prior to the Date of Termination (as defined below). The
Company may also terminate this Agreement and the Term on account of the Consultant’s Disability and the Parties may terminate the Term upon mutual agreement. The Term will terminate automatically in the event of the Consultant’s death (as
defined below). Any termination of this Agreement and the Term, other than a termination on account of the Consultant’s death, shall be communicated by a written “Notice of Termination” to the other party hereto delivered in
accordance with Section 1.4. 
 1.4.1 For purposes of this letter, “Cause” shall mean (i) any refusal by the
Consultant to perform the Services, after written notice thereof by the Company and a reasonable opportunity to cure, not to exceed 30 days (provided such refusal is reasonably susceptible to cure); (ii) any act of dishonesty, fraud,
embezzlement, theft or misappropriation by the Consultant in connection with or related to the performance of the Services hereunder or the indictment of or plea of nolo contendere by the Consultant to any felony or crime involving moral turpitude;
(iii) any gross negligence or willful misconduct by the Consultant in connection with the performance of the Services; or (iv) any breach by the Consultant of any of the material terms contained in this Agreement or any agreement between
the Consultant and the Company or its affiliates, after written notice thereof by the Company and a reasonable opportunity to cure, not to exceed 30 days (provided such breach is reasonably susceptible to cure). For purposes of this Agreement,
“Disability” shall mean the Consultant’s inability to perform the Services due to illness or injury for a period of 90 consecutive calendar days or 90 calendar days in any 180 day period. 

1.4.2 For purposes of the Agreement, “Date of Termination” shall mean, if the Agreement is terminated (i) by the Company
with Cause or by either Party without Cause or by the Company due to the Consultant’s Disability, the date specified in the Notice of Termination, which, in the case of a termination without Cause, shall not be less than 10 days after the date
the Notice of Termination is delivered, or (ii) if the Agreement is terminated for any other reason, the date on which a Notice of Termination is given or any later date (within thirty (30) days, or any alternative time period agreed upon
by the parties, after the giving of such notice) set forth in such Notice of Termination. 

  
 2 

 1.5 Effect of Termination. Upon termination of this Agreement prior to the expiration of
the Term, within thirty (30) days after the Date of Termination, the Company shall pay the Executive a pro-rata Consulting Fee for the portion of the month prior to the Date of Termination and expense reimbursements as of the Date of
Termination, following which the Company’s obligations to pay the Consulting Fee shall immediately cease, and the Consultant shall not be required to render any further Services; provided, however, that if the Company terminates this
Agreement for Cause, the Company’s obligations to pay the Consulting Fee shall immediately cease as of the Date of Termination. 
 1.6
Relationship of Parties. The Consultant is an independent contractor of the Company, and this Agreement shall not be construed to create any association, partnership, joint venture, employee or agency relationship between the Consultant and
the Company (or any of its affiliates) for any purpose. Except to the extent specifically authorized in advance by the Company in writing, the Consultant (a) shall have no authority (and shall not hold itself out as having authority) to
represent, bind or act on behalf or in the name of the Company or any of its affiliates, and (b) shall not make any agreements or representations on behalf of the Company or any of its affiliates. Without limiting the generality of the
foregoing, except as otherwise provided in the Employment Agreement and/or the Separation Agreement (each as defined below), the Consultant will not be eligible to participate in any vacation, group medical or life insurance, disability, profit
sharing or retirement benefits or any other fringe benefits or benefit plans offered by the Company or any of its affiliates to its employees. The Company will not be responsible for withholding or paying any income, payroll, Social Security or
other federal, state or local taxes, making any insurance contributions, including unemployment or disability, or obtaining worker’s compensation insurance on behalf of the Consultant. The Consultant shall be responsible for, and shall
indemnify the Company against, all such taxes or contributions, including penalties and interest. The Consultant may not engage any person in connection with the performance of the Services without the Company’s prior written consent. The
Consultant shall be fully responsible for any such persons and in no event shall the Consultant be relieved of its obligations under this Agreement as a result of its use or engagement of any such persons. 

Section 2 Compensation 

2.1 Consulting Fee. As consideration for the provision of Services and the rights granted to the Company under this Agreement, the
Consultant shall be paid a monthly consulting fee of $19,000, payable in arrears, no later than the fifteenth (15th) day of the following month (the “Consulting Fee”). 

2.2 Expense Reimbursement. The Company agrees to reimburse the Consultant for reasonable and appropriately documented out-of-pocket
expenses actually incurred and paid by the Consultant but only to the extent (a) directly related to the Consultant’s performance of the Services, (b) incurred in accordance with the Company’s expense reimbursement policies and
(c) approved in writing in advance by the Company. All reimbursements provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A of the Code to the extent that such reimbursements are
subject to Section 409A of the Code, including, where applicable, the requirements that (a) any reimbursement is for expenses incurred during the Term, (b) the amount of expenses eligible for reimbursement during a calendar year may
not affect the expenses eligible for reimbursement in any other calendar year, (c) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred and
(d) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit. 

  
 3 

 2.3 Withholding, etc. Amounts payable under this Agreement shall be without deduction or
withholding of any kind other than any tax or other deduction or withholding determined by the Company to be required by law. Except as otherwise provided herein, the Company shall be entitled to set-off against and deduct from any amount payable to
the Consultant hereunder any amount which it in good faith considers to be due to the Company or any of it’s affiliates under the terms of this Agreement or any other agreement involving the Parties or their respective affiliates. 

Section 3 Certain Agreements 

3.1 Non-Competition. Nothing in this Agreement shall restrict the Consultant from being engaged or employed in any other business,
trade, profession or other activity; provided, that, during the Term, to the maximum extent permitted by Law, the Consultant shall not, directly or indirectly, engage in, become financially interested in, be employed by or have any business
connection other than as a member of the board of directors or similar governing body, with any other person, corporation, firm, partnership or other entity whatsoever (a “Competitor”) known by him to Compete with the Company, anywhere in
the world, in any line of business engaged in (or planned to be engaged in) by the Company or any of its affiliates, in each case, without the Company’s prior written consent; provided, further, that nothing in this Agreement
shall prohibit you from holding, as a passive investor and for investment purposes only, no more than five percent (5%) of the capital stock of any publicly traded company or any privately held company (without any other involvement in the
management or operation of such business). For the purposes of this paragraph 3.1, a Competitor shall be deemed to “Compete” if it engages in the development, manufacture, and sale (other than at the retail level) of branded and generic
drug products and that is in material and direct competition with any of the five (5) products that, over the four (4) fiscal quarters immediately preceding your Termination Date, accounted for the greatest amount of revenues for the
Company or any of its affiliates, taken as a whole. 
 3.2 Confidentiality. The Consultant shall (a) use the Confidential
Information solely to the extent necessary in the performance of the Services and not for any other purpose, (b) not disclose any Confidential Information other than in connection with the provision of Services, (c) promptly return all
Confidential Information to the Company (or, at the election of the Company, destroy such Confidential Information) without retaining any copies thereof and (d) not reverse engineer, decompile, test or analyze the Confidential Information
without the prior written consent of the Company. In the event that the Consultant is requested or required by law, judicial or governmental order, deposition, interrogatory, request for documents, subpoena, civil investigative demand or other legal
process to disclose any of the Confidential Information, the Consultant must first provide the Company with prompt written notice of such requirement so that the Company (or any of its affiliates) may seek an appropriate protective order. If the
Consultant is nevertheless legally required (as confirmed by the opinion of the Company’s counsel) to disclose Confidential Information, then the Consultant shall only disclose that portion of the Confidential Information that is legally
required to be disclosed (as confirmed by the opinion of the Company’s counsel). In such an event, the Consultant shall take reasonable efforts to obtain assurance that confidential treatment will be accorded to that portion of the Confidential
Information being disclosed. In no event shall the Consultant oppose action by the Company (or any of its affiliates) to obtain an appropriate protective order or other reliable assurance that confidential treatment will be accorded the Confidential
Information. For purposes 

  
 4 

 
of this section, “Confidential Information” means all non-public information concerning the Company or any of its affiliates (whether prepared by the Company or otherwise,
whether oral or written, in whatever form or data storage medium and whether or not specifically identified as “confidential”), including plans and strategies, financial and accounting information, product-related information, computer
programs, code and software, technical drawings and schematics, technical expertise, know-how, processes, ideas, inventions (whether patentable or not), agreements and reports (together with all analyses, compilations, forecasts, studies, summaries,
notes, data and other documents and materials, in whatever form maintained and whether prepared by the Company, the Consultant or other persons, which contain or reflect, or are based on or generated from, in whole or in part, any such information).

 3.3 Proprietary Items. The Consultant will not remove from the Company or any of the Company’s premises (except to the extent
such removal is for purposes of the performance of Consultant’s duties hereunder at home or while traveling, or except as otherwise specifically authorized by the Company) any document, record, notebook, plan, model, component, device, or
computer software, whether embodied in a disk or in any other form (collectively, the “Proprietary Items”). The Consultant recognizes that, as between the Company, on the one hand, and the Consultant, on the other hand, all of the
Proprietary Items, whether or not developed by the Consultant, are the exclusive property of the Company. Upon any termination of the Term or this Agreement, or upon the Company’s request at any time, the Consultant will return to the Company
all of the Proprietary Items in the Consultant’s possession or subject to the Consultant’s control, and the Consultant shall not retain any copies or other physical embodiment of any of the Proprietary Items. 

3.4 Other. Nothing in this Section 3 shall limit any other non-compete, non-solicitation, confidentiality, intellectual
property-related or other covenants or restrictions to which the Consultant may be subject under any other agreement, including Section 8 of the Key Employee Agreement between the Consultant and Watson Pharmaceuticals Inc., dated
February 28, 2000, as amended (the “Employment Agreement”), the Separation Agreement and Release between Consultant and the Company, dated March __, 2015 (the “Separation Agreement”) or otherwise. This
Section 3 shall survive the termination of this Agreement. 
 Section 4 Miscellaneous 

4.1 Notice. All notices, approvals and other communications required or contemplated under this Agreement shall be in writing and shall
be deemed to have been duly given (a) when received if delivered personally, (b) when sent by cable, telecopy, telegram or facsimile (which is confirmed by the intended recipient), and (c) when sent by overnight courier service or
when mailed by certified or registered mail, return receipt requested, with postage prepaid, to the Parties at the following addresses: 
  

			
	In the case of Consultant:		to the most recent address on file with the Company
		
	In the case of the Company:		Actavis plc
			Morris Corporate Center III
			400 Interpace Parkway
			Parsippany, New Jersey 07054
			Attention: Chief Legal Officer & Secretary

  
 5 

			
		
	with a copy to:		Actavis plc
			1 Grand Canal Square
			Docklands
			Dublin 2
			 Ireland

			Attention: Chief Legal Officer & Secretary

 or such other persons or addresses as either Party may from time to time designate by notice to the other. 

4.2 Assignment; Binding Effect. No Party shall assign or transfer or purport to assign or transfer any of its rights or obligations
under this Agreement without the prior written consent of the other Party; provided, however, that the Company shall be permitted to assign or transfer any of its rights or obligations hereunder to any affiliate of the Company without
the written consent of the Consultant. This Agreement shall inure to the benefit of the Parties and their respective permitted successors and assigns and is binding upon the Parties and their respective successors and assigns. 

4.3 Amendment; Waiver. This Agreement may be amended, changed or supplemented only by a written agreement executed and delivered by the
Parties. Any waiver of, or consent to depart from, the requirements of any provision of this Agreement shall be effective only if it is in writing and signed by the Party giving it, and only in the specific instance and for the specific purpose for
which it has been given. Except as otherwise provided by this Agreement, no failure on the part of any Party to exercise, and no delay in exercising any right under this Agreement shall operate as a waiver of such right. 

4.4 Entire Agreement. This Agreement (including the Annex), Section 8 of the Employment Agreement and the Separation Agreement
constitute the entire agreement between the Parties pertaining to the subject matter hereof and supersedes all prior agreements, negotiations, discussions and understandings, written or oral, between the Parties with respect to such subject matter.

 4.5 Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. The Parties shall negotiate in good faith to amend this
Agreement to give effect to the purpose and intent of the provision found to be invalid, illegal or unenforceable. 
 4.6 Governing Law;
Dispute Resolution. This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey, without regard to principles of conflict of laws. The parties agree that any controversy or claim not resolved by the
Parties arising out of or relating to this Agreement shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration held in Morris County, New Jersey and conducted, to the extent not inconsistent with the
laws of the State of New Jersey, pursuant to the Rules for Arbitration of Employment Disputes of the American Arbitration Association, and the parties agree that each side shall initially bear their own costs and fees, but that the arbitrator may
award reasonable costs and attorney’s fees to the prevailing party. 

  
 6 

 4.7 Costs. Except as otherwise provided in this Agreement, each Party is responsible for
its own costs and expenses incurred in connection with performing and observing its obligations and covenants under this Agreement. 
 4.8
Remedies. The Consultant expressly acknowledges and agrees that the terms of this Agreement are reasonable and necessary for the protection of the legitimate business interests of the Company. The Consultant acknowledges and agrees that the
Company would be irreparably harmed by a breach of this Agreement by the Consultant and that money damages are an inadequate remedy for an actual or threatened breach of this Agreement. Therefore, the Consultant agrees to the granting of specific
performance of this Agreement and injunctive or other equitable relief in favor of the Company as a remedy for any such breach, without proof of actual damages, and the Consultant further waives any requirement for the securing or posting of any
bond in connection with any such remedy. Such remedy shall not be deemed to be the exclusive remedy for any such breach, but shall be in addition to all other remedies available at law or equity to the Company. 

4.9 Counterparts. This Agreement may be executed in any number of counterparts which, taken together, constitute one and the same
agreement. 
 4.10 No Third Party Beneficiaries. Except as expressly contemplated by this Agreement, nothing in this Agreement shall
confer any rights upon any person other than the Parties and their respective successors and permitted assigns. 
 [remainder of
this page has been left blank intentionally] 

  
 7 

 IN WITNESS WHEREOF, the Company and the Consultant have each caused this Agreement to be duly
executed pursuant to due authorization, all as of the day and year first above written. 
  

			
	ACTAVIS PLC
		
	By:		/s/ Karen L. Ling
	Name:		Karen L. Ling
	Title:		Chief Human Resources Officer

  

			
	CONSULTANT
		
	By:		/s/ David A. Buchen
	Name:		David A. Buchen

  

 Annex A 

Services 
 The Consultant is engaged to
provide the following services:EX-10.40

 Exhibit 10.40 

May 19, 2014 
 David Buchen 

15 Jacob Arnold Road 
 Morristown, NJ 07960 

Dear David: 
 You have been identified as a key contributor to
the success of Actavis plc, its subsidiaries and affiliates (the “Company”) and the success of its pending acquisition of Forest Laboratories, Inc. (the “Forest Transaction”). In recognition of your contributions, the Company is
pleased to offer you a special retention, as set forth below, which is contingent upon your acceptance of the terms of this letter. 
 Special Retention
Award 
 In the event your employment is terminated at any time by you for “Good Reason” (as defined in the February 28, 2000 Key
Employment Agreement between you and Actavis, Inc. (f/k/a Watson Pharmaceuticals, Inc.), as amended from time to time (the “Employment Agreement”)), the following benefits will be due to you: (i) a lump sum equal to the sum of two
times your current annual base salary and two times your annual incentive bonus (calculated based on the higher of your target bonus or the highest bonus you have received in the two years prior to your termination); (ii) any earned but unpaid
bonus for the year preceding your termination; (iii) a pro-rated bonus (based on your target bonus) for the year in which your termination occurs; (iv) continued group health insurance benefits for up to twenty four months; and
(v) outplacement services for one year with a nationally recognized service selected by the Company, which shall be paid or reimbursed promptly by the Company, but in no event later than the calendar year immediately following the calendar year
which such expenses are incurred. In the event your employment is terminated at any time by the Company without “Cause” (as defined in the Employment Agreement), you shall be paid the forgoing compensation and benefits, unless that on the
date of your termination the Company then provides the Company’s senior executives with more valuable severance and compensation and benefits, in the aggregate, than the forgoing compensation and benefits, in which case you shall be paid such
more valuable benefits. In addition, provided that you are employed by the Company on January 2, 2015, you shall be paid the forgoing compensation and benefits if you are not the Chief Legal Officer & Secretary of Actavis plc, with all
commensurate duties and responsibilities of such office and title, on such date and if you elect to terminate your employment with the Company, for any reason or no reason, no later than the earlier of (a) the first anniversary of the
consummation of the Forest Transaction or (b) December 1, 2015. The forgoing severance benefits and compensation shall be paid to you subject to your delivery, execution and non-revocation of a Release and such amounts shall be paid to you
within 30 days after your qualifying termination of employment, and if the 30-day period during which the severance benefits may be paid spans two calendar years, the payment shall be made in the later calendar year. 

 This letter does not change, in any way, the nature of your employment relationship with the Company. You or the
Company may terminate your employment at any time, for any reason, with or without Cause, except to the extent otherwise expressly provided by any written agreement between you and the Company. The compensation and benefits provided in this letter
are intended to be compliant with Section 409A of the Internal Revenue Code and the provisions hereof shall be interpreted and administered consistently with such intent. Additionally, this letter is in addition to, and does not alter,
supersede or replace any prior retention agreement between you and the Company 
 We are confident we can count on your continued support. On behalf of the
Company, I thank you for your contributions to the Company’s success. Please indicate your acknowledgement and acceptance of this offer by signing and returning a copy of the letter. 

 

	
	Sincerely yours,
	
	/s/ Paul M. Bisaro
	Paul M. Bisaro
	Chairman and Chief Executive Officer

 Date 

 Acknowledgement 
 I
have read, understand and accept the terms set forth in this letter. 
  

							
	/s/ David A. Buchen						May 23, 2014
							Date

 Appendix A 

“Cause” For the purposes of this offer of the Retention Bonus, “Cause” shall mean the occurrence of any of the following events on
or after acceptance of this offer, and upon written notice to Executive and a reasonable opportunity for the Executive to cure such event (which opportunity shall be thirty (30) days unless the event is not susceptible to being cured, within
the judgment of the Board): (i) fraud, misappropriation, embezzlement or other act of material misconduct against the Company or any of its affiliates; (ii) gross neglect, willful malfeasance or gross misconduct against the Company or any
of its affiliates; (iii) conviction or plea of guilty or nolo contendere to a felony which felony, conviction, or plea materially impacts the Company economically or the Company’s reputation, as reasonably determined by the Board;
(iv) willful and knowing violation of any rules or regulations of any governmental or regulatory body material to the business of the Company; (v) failure to cooperate, if requested by the Board, with any investigation or inquiry into
Executive’s or the Company’s business practices, whether internal or external, including, but not limited to Executive’s refusal to be deposed or to provide testimony at any trial or inquiry unless such refusal is made upon the advice
of the Company’s general counsel or its external counsel; or (vi) substantial and willful failure to render services in accordance with the terms of Executive’s employment (other than as a result of illness, accident, or other
physical or mental incapacity) or other material breach of Executive’s duties and responsibilities). For the purposes of clauses (ii), (iv) and (vi) of this definition, no act, or failure to act, on Executive’s part shall be
deemed “willful” unless done, or omitted to be done, by Executive not in good faith and with reasonable belief that Executive’s act, or failure to act, was in the best interest of the Company. Notwithstanding the foregoing, the
Company shall not have “Cause” to terminate Executive’s employment in connection with any of the foregoing events to the extent that the Company shall have either consented to such event or the extent that ninety (90) days shall
have elapsed following the date that the Company becomes aware of such event without delivering notice to the Executive (“Cause Notice”). 

“Good Reason” For the purposes of this letter, “Good Reason” shall mean any one of the following events which occurs on or after
acceptance of this offer: (i) any material reduction of the Executive’s then existing annual base salary, except to the extent the annual base salary of all other executive officers at levels similar to the Executive of the Company is
similarly reduced (provided such reduction does not exceed fifteen percent (15%) of Executive’s then existing annual base salary); (ii) any material reduction in the package of benefits and incentives, taken as a whole, provided to
the Executive (except that employee contributions may be raised to the extent of any cost increases imposed by third parties) or any action by the Company which would materially and adversely affect the Executive’s participation or reduce the
Executive’s benefits under any such plans, except to the extent that such benefits and incentives of all other executive officers at a similar level of the Company are similarly reduced; (iii) any material diminution of the
Executive’s duties and responsibilities, taken as a whole, excluding for this purpose an isolated, insubstantial or inadvertent action not taken in bad faith which is remedied by the Company immediately after notice thereof is given by the
Executive; (iv) a requirement that the Executive materially relocate to a work site that would increase the Executive’s one-way commute distance by more than thirty-five (35) miles from his then principal residence, unless the
Executive accepts such relocation opportunity; (v) any material breach by the Company of its obligations under 

 this Agreement; or (vi) any failure by the Company to obtain the assumption of this Agreement by any
successor or assign of the Company. Notwithstanding the foregoing, the Executive may not resign his employment for Good Reason unless: (A) the Executive has provided the Company with at least 30 days prior written notice of the Executive’s
intent to resign for Good Reason; and (B) the Company has not remedied the alleged violation(s) within 30 days following its receipt of the written notice of intent to resign for Good Reason.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]